Related Experiment Videos
Lung transplantation for pulmonary sarcoidosis
1Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, USA.
The European Respiratory Journal
|May 22, 1998
Summary
Lung transplantation is a viable option for end-stage sarcoidosis patients, offering good outcomes. Careful patient selection and management of unique disease considerations are crucial for successful outcomes in lung transplant recipients.
Area of Science:
- Pulmonology
- Immunology
- Transplant Surgery
Background:
- Sarcoidosis is a multisystem inflammatory disease that can lead to end-stage lung disease.
- Lung transplantation is an option for patients with severe pulmonary sarcoidosis when medical therapies fail.
Purpose of the Study:
- To review the considerations and outcomes of lung transplantation in patients with sarcoidosis.
- To highlight the unique challenges and disease-specific factors influencing transplant candidacy and post-transplant management.
Main Methods:
- Review of existing literature and case series on lung transplantation for sarcoidosis.
- Analysis of patient selection criteria, surgical considerations, and post-transplant outcomes.
- Assessment of disease recurrence, rejection episodes, and long-term graft survival.
Main Results:
- Lung transplantation has demonstrated good short- and intermediate-term results in selected sarcoidosis patients.
- Disease recurrence in the allograft is common but typically asymptomatic.
- While more severe acute rejection can occur, there is no current evidence of increased risk for obliterative bronchiolitis or mortality.
Conclusions:
- Lung transplantation is a successful treatment for end-stage pulmonary sarcoidosis.
- Careful pre-transplant evaluation, including exclusion of other pulmonary pathologies and assessment of extrapulmonary disease, is essential.
- Ongoing monitoring for allograft recurrence and rejection is necessary, though outcomes remain favorable.